Cargando…
N6-methyladenine-modified DNA was decreased in Alzheimer’s disease patients
BACKGROUND: In recent years, the prevalence of Alzheimer’s disease (AD) has increased, which places a great burden on society and families and creates considerable challenges for medical services. N6-methyladenine (m6A) deoxyribonucleic acid (DNA) adenine methylation is a novel biomarker and is abun...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771380/ https://www.ncbi.nlm.nih.gov/pubmed/35097069 http://dx.doi.org/10.12998/wjcc.v10.i2.448 |